Jasper Therapeutics Inc - Units (1 Ord Class A & 1/2 War)
AMHCU
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.64M
Close$
$10.96
0% upside
Current Fair Value
0% upsideOvervalued by 0% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.64 Million |
|---|---|
| Enterprise Value | $4.59 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 0 |
| Outstanding Shares | 28,696,937 |
Return
| Return on Equity | -2165.39% |
|---|---|
| Return on Assets | -259.25% |
| Return on Invested Capital | -1231.16% |
Valuation & Multiples
| P/E Ratio | -10.88 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.09 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jasper Therapeutics Inc
3 employees